Serum microRNA markers of tuberculoma decoy.

V. Evstifeev (Moscow, Russian Federation), G. Shepelkova (Moscow, Russian Federation), A. Ergeshova (Moscow, Russian Federation), A. Guskov (Moscow, Russian Federation), M. Bagirov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation)

Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Session: Tuberculosis: from basic science to patient care
Session type: Thematic Poster
Number: 4596
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Evstifeev (Moscow, Russian Federation), G. Shepelkova (Moscow, Russian Federation), A. Ergeshova (Moscow, Russian Federation), A. Guskov (Moscow, Russian Federation), M. Bagirov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation). Serum microRNA markers of tuberculoma decoy.. 4596

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum markers of acute sarcoidosis.
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease?
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


Serum kinetics of total leptin and soluble leptin receptor as prognostic tools in sepsis.
Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Year: 2019


Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004

Serum microRNA signatures identified in a genome-wide profiling predict the mortality of patients with sepsis
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011


The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis?
Source: International Congress 2017 – Rare diseases
Year: 2017


Serum markers of IPF
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004


Identification of miR-21 as a regulator of mesothelin expression using microRNA capture affinity coupled with next generation sequencing
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016

Serum amyloid A as a potential biomarker of sarcoidosis
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011

Circulating total leptin as a diagnostic and prognostic biomarker in sepsis
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019


Gene expression profiles of idiopathic interstitial pneumonias: Identification of disease-specific diagnostic markers and molecular therapeutic targets
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012


Characterization of miRNAs circulating in sepsis patients‘ serum
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011


A set of microRNA markers of active tuberculosis.
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020


Plasma circulating miRNAs as diagnostic and prognostic biomarkers in alpha-1 antitrypsin deficiency.
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019

Levels of IGFBP-1, MMP-9 and circulating nucleosomes: a new model to diagnose SSc-ILD
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Chemokine mRNA expression profiling in pulmonary sarcoidosis
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008

The clinical significance of serum osteoprotegerin (OPG) and pro-gastrin-releasing peptide (ProGRP) concentrations in lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 318s
Year: 2004

The Pleural and blood gene expression level of GBP5 and STAT1 were associated with pleural tuberculosis: TB pleura diagnostic biomarkers.
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019


Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis
Source: Eur Respir J 2009; 34: 1376-1382
Year: 2009



Development of a new sensitive ELISA for the determination in serum of uteroglobin-related protein 1 (UGRP-1), a new potential lung biomarker
Source: Annual Congress 2010 - Innovations in the assessment of airway diseases
Year: 2010